Hypophysitis: Defining Histopathologic Variants and a Review of Emerging Clinical Causative Entities
CA Rawanduzy, A Winkler-Schwartz… - International Journal of …, 2023 - mdpi.com
Inflammatory disease of the pituitary gland is known as hypophysitis. There are multiple
histological subtypes, the most common being lymphocytic, and the pathogenesis is variable …
histological subtypes, the most common being lymphocytic, and the pathogenesis is variable …
Immunotherapy-associated hypophysitis under anti-PD1: two case reports
X Shen, M Yang, H Xu, H Zhou… - Endocrine, Metabolic & …, 2023 - ingentaconnect.com
Background: Immunotherapy-associated hypophysitis is an uncommon adverse event.
However, if not handled properly, it could lead to fatal sequelae. Case Presentations: Case …
However, if not handled properly, it could lead to fatal sequelae. Case Presentations: Case …
Immune checkpoint inhibitor induced hypophysitis: a specific disease of corticotrophs?
N Patel, K Hirwa, G Gardner, K Pearce… - Endocrine …, 2024 - ec.bioscientifica.com
Introduction The aim of this study was to define functional and anatomical pituitary disease
at the time of presentation following immune checkpoint inhibitor (ICI) therapy and to …
at the time of presentation following immune checkpoint inhibitor (ICI) therapy and to …
[HTML][HTML] Immunotherapy-Induced Hypophysitis Following Treatment With Tislelizumab in an Elderly Patient With Bladder Cancer and Prostate Cancer: A Case Report
N Zhang, X Qu, X Zhang, X Sun, L Kang - Cureus, 2023 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors represent a hopeful and emerging group of medications
employed in the regulation of the immune response against cancer, displaying tremendous …
employed in the regulation of the immune response against cancer, displaying tremendous …
[PDF][PDF] Immunotherapy-Induced Hypophysitis Following ICI Treatment With Tislelizumab in an Elderly Patient With Bladder Cancer and Prostate Cancer: A Case …
N Zhang, X Qu, X Zhang, X Sun, L Kang - 2023 - assets.cureus.com
Immune checkpoint inhibitors represent a hopeful and emerging group of medications
employed in the regulation of the immune response against cancer, displaying tremendous …
employed in the regulation of the immune response against cancer, displaying tremendous …
PD-1/PD-L1 Inhibitors-Induced Hypophysitis: A real-world retrospective cohort study
YY Zhu, XY Zhang, SM Luo, YY Xu, JH Huang - 2023 - researchsquare.com
Purpose: The main purposes and research question was to describe the clinical, laboratory,
imageology and morphological characteristics of hypophysitis induced by PD-1/PD-L1 …
imageology and morphological characteristics of hypophysitis induced by PD-1/PD-L1 …